{"name":"Farma de Colombia SA","slug":"farma-de-colombia-sa","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"GROUP C: Chlorthalidone","genericName":"GROUP C: Chlorthalidone","slug":"group-c-chlorthalidone","indication":"Hypertension","status":"phase_3"}]}],"pipeline":[{"name":"GROUP C: Chlorthalidone","genericName":"GROUP C: Chlorthalidone","slug":"group-c-chlorthalidone","phase":"phase_3","mechanism":"Chlorthalidone is a thiazide-like diuretic that inhibits sodium and chloride reabsorption in the distal convoluted tubule of the kidney, promoting urinary excretion and reducing blood volume and blood pressure.","indications":["Hypertension","Edema associated with congestive heart failure or renal disease"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE1Tdk9ucF9pM3BlOTJfdmMtZUpTaWxRM3BiSGpyUGRrNERQNkhmOUcxRVJIQy1lUS1HNnRoZlZid1VRb2FoTDlBYks3bndxNEozbDBhUldWcWlCWER4UjdGYQ?oc=5","date":"2022-05-11","type":"deal","source":"复宏汉霖","summary":"Henlius and Eurofarma Entered into a License Agreement for Henlius' 3 Products in Latin America - 复宏汉霖","headline":"Henlius and Eurofarma Entered into a License Agreement for Henlius' 3 Products in Latin America - 复宏汉霖","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wJBVV95cUxOTWhERjZrdjNhZTF6WW5tYkdaR29yUkRod2NYWnEzUGYyeGhTenkzS3NCVV8xVk8yQU1VYjNobE5jdTY5S29EMU13QUx1T2ZjaVFTOEloNzdHQmZPeXZrSS02RmVJTlV4cndGcTZDZ0E1QXlNbVQ4U2lOSDMzMGk1QWlYMFpYZndfek1UUG9QMDA0N2NUeDFqaWFJdmc1U0RkTnJRdVlmeHFuT2gyNzFrNjViWm9oVVdUdlVIdG94eTRJWUJxVlVKbF80NGhLVFBnZnB4OXQ5elY5cmVrTWQ4LTR2SG9jNTZiV05xTWhMWUszb0R5dHI5Y0tFY1Z3QmhkYWpNWDJsS2ZNRjRlYjIzbE1sWDY0YTU5dmN3X2NISkEzZUltbk05d0ZEZGJvZVNLOWpMY1U5SHNINmRycGJNcEUxMUk3eVRvelpQS3A1NWZpN052S1pLcmxhM2hRenJaNXkw?oc=5","date":"2020-02-12","type":"pipeline","source":"PR Newswire","summary":"Norgine B.V. Enters Into Exclusive Licence and Distribution Agreements for the Commercialisation of PLENVU® in a Number of Countries in Latin America, Southern Africa, Central and Eastern Europe - PR ","headline":"Norgine B.V. Enters Into Exclusive Licence and Distribution Agreements for the Commercialisation of PLENVU® in a Number ","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}